Johnson K - Search Results

1

Discovery and SAR studies of novel GlyT1 inhibitors.

Walter MW, Hoffman BJ, Gordon K, Johnson K, Love P, Jones M, Man T, Phebus L, Reel JK, Rudyk HC, Shannon H, Svensson K, Yu H, Valli MJ, Porter WJ. Walter MW, et al. Among authors: johnson k. Bioorg Med Chem Lett. 2007 Sep 15;17(18):5233-8. doi: 10.1016/j.bmcl.2007.06.074. Epub 2007 Jun 30. Bioorg Med Chem Lett. 2007. PMID: 17629697

2

3-Aryl-1,2-diacetamidopropane derivatives as novel and potent NK-1 receptor antagonists.

Hipskind PA, Howbert JJ, Bruns RF, Cho SS, Crowell TA, Foreman MM, Gehlert DR, Iyengar S, Johnson KW, Krushinski JH, Li DL, Lobb KL, Mason NR, Muehl BS, Nixon JA, Phebus LA, Regoli D, Simmons RM, Threlkeld PG, Waters DC, Gitter BD. Hipskind PA, et al. Among authors: johnson kw. J Med Chem. 1996 Feb 2;39(3):736-48. doi: 10.1021/jm950616c. J Med Chem. 1996. PMID: 8576917

3

The non-peptide NK-1 receptor antagonist LY303870 inhibits neurogenic dural inflammation in guinea pigs.

Phebus LA, Johnson KW, Stengel PW, Lobb KL, Nixon JA, Hipskind PA. Phebus LA, et al. Among authors: johnson kw. Life Sci. 1997;60(18):1553-61. doi: 10.1016/s0024-3205(97)00121-5. Life Sci. 1997. PMID: 9126877

4

5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs.

Johnson KW, Schaus JM, Durkin MM, Audia JE, Kaldor SW, Flaugh ME, Adham N, Zgombick JM, Cohen ML, Branchek TA, Phebus LA. Johnson KW, et al. Neuroreport. 1997 Jul 7;8(9-10):2237-40. doi: 10.1097/00001756-199707070-00029. Neuroreport. 1997. PMID: 9243618

5

Migraine therapy: relationship between serotonergic contractile receptors in canine and rabbit saphenous veins to human cerebral and coronary arteries.

Cohen ML, Johnson KW, Schenck KW, Phebus LA. Cohen ML, et al. Among authors: johnson kw. Cephalalgia. 1997 Oct;17(6):631-8. doi: 10.1046/j.1468-2982.1997.1706631.x. Cephalalgia. 1997. PMID: 9350382

6

A fluorescence-based method for assessing dural protein extravasation induced by trigeminal ganglion stimulation.

Johnson KW, Phebus LA. Johnson KW, et al. J Neurosci Methods. 1998 Jun 1;81(1-2):19-24. doi: 10.1016/s0165-0270(98)00010-7. J Neurosci Methods. 1998. PMID: 9696305

7

Human 5-HT1F receptor-stimulated [35S]GTPgammaS binding: correlation with inhibition of guinea pig dural plasma protein extravasation.

Wainscott DB, Johnson KW, Phebus LA, Schaus JM, Nelson DL. Wainscott DB, et al. Among authors: johnson kw. Eur J Pharmacol. 1998 Jul 3;352(1):117-24. doi: 10.1016/s0014-2999(98)00336-7. Eur J Pharmacol. 1998. PMID: 9718276

8

Serotonin in migraine: theories, animal models and emerging therapies.

Johnson KW, Phebus LA, Cohen ML. Johnson KW, et al. Prog Drug Res. 1998;51:219-44. doi: 10.1007/978-3-0348-8845-5_6. Prog Drug Res. 1998. PMID: 9949863 Review.

9

Lanepitant, an NK-1 antagonist, in migraine prevention.

Goldstein DJ, Offen WW, Klein EG, Phebus LA, Hipskind P, Johnson KW, Ryan RE Jr. Goldstein DJ, et al. Among authors: johnson kw. Cephalalgia. 2001 Mar;21(2):102-6. doi: 10.1046/j.1468-2982.2001.00161.x. Cephalalgia. 2001. PMID: 11422091 Clinical Trial.

10

Selective seratonin 1F (5-HT(1F)) receptor agonist LY334370 for acute migraine: a randomised controlled trial.

Goldstein DJ, Roon KI, Offen WW, Ramadan NM, Phebus LA, Johnson KW, Schaus JM, Ferrari MD. Goldstein DJ, et al. Among authors: johnson kw. Lancet. 2001 Oct 13;358(9289):1230-4. doi: 10.1016/s0140-6736(01)06347-4. Lancet. 2001. PMID: 11675061 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,195 results

Search Page